| Date | Company | Compound | Disease | Type of agreement | Therapeutic area | Type of Information |
|---|---|---|---|---|---|---|
| 2016-11-28 | Lion Biotechnologies (USA - CA) WuXi AppTec (China) | autologous cell therapy products | manufacturing - production | Technology - Services | Production agreement | |
| 2016-11-24 | Novasep (France) Vaccine Research Institute (France) ANRS (National Agency for Research on AIDS and viral hepatitis) (France) | two experimental vaccines | HIV infection | production manufacturing |
Infectious diseases | Production agreement |
| 2016-11-23 | Navidea Biopharmaceuticals (USA - OH) Cardinal Health (USA - OH) | Lymphoseek®(technetium Tc 99m tilmanocept) | product acquisition |
Cancer - Oncology - Diagnostic | Product acquisition | |
| 2016-11-23 | Prima Biomed (Australia) WuXi Biologics (China) | IMP321 | development manufacturing bioproduction |
Cancer - Oncology | Development agreement | |
| 2016-11-23 | Neovacs (France) 3P Biopharmaceuticals (Spain) | interferon alpha | manufacturing production |
Technology - Services | Production agreement | |
| 2016-11-22 | Shire (UK - USA) | Kendall Square campus | opening of new premises |
Rare diseases | Opening of new premises | |
| 2016-11-22 | PCT, a Caladrius Company (USA - CA) | validation of a production plant | Technology - Services | Validation of a production plant | ||
| 2016-11-22 | Autolus (UK) Cell and Gene Therapy Catapult (UK) | production - manufacturing | Production agreement | |||
| 2016-11-21 | Abbvie (USA - IL) Halozyme Therapeutics (USA - CA) | Enhanze™ platform | licensing development commercialisation |
Technology - Services | Licensing agreement | |
| 2016-11-21 | BiolineRx (Israel) Yissum Research Development Company of the Hebrew University of Jerusalem (Israel) | BL-1230 | dry eye syndrome | licensing |
Ophtalmological diseases | Licensing agreement |
| 2016-11-18 | Celgene (USA - NJ) PharmAkea (USA - CA) | collaboration | Cancer - Oncology - Fibrotic diseases | Collaboration agreement | ||
| 2016-11-16 | Gilead Sciences (USA - CA) | nomination |
Infectious diseases - Cancer - Oncology - Hepatic diseases - Liver diseases | Nomination | ||
| 2016-11-16 | BMS (USA - NY) Enterome (France) | microbiome-derived biomarkers, drug targets and bioactive molecules | R&D |
Cancer - Oncology | R&D agreement | |
| 2016-11-15 | PharmaMar (Spain) | nomination |
Cancer - Oncology | Nomination | ||
| 2016-11-15 | Neovacs (France) Amegabiotech (Argentina) | interferon alpha manufacturing license | licensing |
Technology - Services | Licensing agreement | |
| 2016-11-15 | Pharmaxis (Australia) Woolcock Institute of Medical Research (Australia) | Orbital® Inhaler with a dry powder formulation of tobramycin | cystic fibrosis | research - R&D | Rare diseases - Genetic diseases | Research agreement |
| 2016-11-15 | Rigontec (Germany) | chief scientific officer | nomination | Cancer - Oncology | Nomination | |
| 2016-11-14 | Curis (USA - MA) | nomination |
Cancer - Oncology | Nomination | ||
| 2016-11-10 | Amgen (USA - CA) Janssen Biotech, a J&J company (USA - NJ) | Kyprolis® (carfilzomib) and Darzalex® (daratumumab) | multiple myeloma | clinical research |
Cancer - Oncology | Clinical research agreement |
| 2016-11-10 | BMS (USA - NY) The Johns Hopkins University (USA - MD) | mechanisms of response and resistance in patients whose cancer is being treated with checkpoint inhibitor-based immunotherapies | R&D |
Cancer - Oncology | R&D agreement |
